Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression
Kim Ohl, Klaus Tenbrock
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 300

Showing 26-50 of 300 citing articles:

Neutrophil Maturity in Cancer
John B. G. Mackey, Seth B. Coffelt, Leo M. Carlin
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 96
AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging
Antero Salminen, Anu Kauppinen, Kai Kaarniranta
Journal of Molecular Medicine (2019) Vol. 97, Iss. 8, pp. 1049-1064
Open Access | Times Cited: 94
Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy
Adeleye O. Adeshakin, Wan Liu, Funmilayo O. Adeshakin, et al.
Cellular Immunology (2021) Vol. 362, pp. 104286-104286
Open Access | Times Cited: 86
Increased immunosuppression impairs tissue homeostasis with aging and age-related diseases
Antero Salminen
Journal of Molecular Medicine (2020) Vol. 99, Iss. 1, pp. 1-20
Open Access | Times Cited: 83
Single‐Cell Transcriptome Profiling Reveals Multicellular Ecosystem of Nucleus Pulposus during Degeneration Progression
Ji Tu, Wentian Li, Sidong Yang, et al.
Advanced Science (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 78
Nanotransferrin-Based Programmable Catalysis Mediates Three-Pronged Induction of Oxidative Stress to Enhance Cancer Immunotherapy
Shuang Bai, Zhixiang Lu, Yonghe Jiang, et al.
ACS Nano (2021) Vol. 16, Iss. 1, pp. 997-1012
Closed Access | Times Cited: 77
The role of extracellular vesicles and PD-L1 in glioblastoma-mediated immunosuppressive monocyte induction
Benjamin Himes, Timothy E. Peterson, Tristan de Mooij, et al.
Neuro-Oncology (2020) Vol. 22, Iss. 7, pp. 967-978
Open Access | Times Cited: 76
Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad
Augusto Bleve, Barbara Durante, Antonio Sica, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5845-5845
Open Access | Times Cited: 74
Redox Homeostasis and Metabolism in Cancer: A Complex Mechanism and Potential Targeted Therapeutics
Alia Ghoneum, Ammar Yasser Abdulfattah, Bailey Warren, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3100-3100
Open Access | Times Cited: 73
Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation
Tiansheng Li, Chao Mao, Xiang Wang, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 71
Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy
Cristina Zalfa, Silke Paust
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 71
Landscape of Myeloid-derived Suppressor Cell in Tumor Immunotherapy
Zhaonian Hao, Ruyuan Li, Yuanyuan Wang, et al.
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 69
The Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context
Faliang Xing, Qiangsheng Hu, Yi Qin, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 69
Myeloid-Derived Suppressor Cells in Solid Tumors
Tianmiao Ma, Bernhard W. Renz, Matthias Ilmer, et al.
Cells (2022) Vol. 11, Iss. 2, pp. 310-310
Open Access | Times Cited: 64
Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
Xidan Gao, Hongshu Sui, Shang Zhao, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 61
Acetylcholine ameliorates colitis by promoting IL-10 secretion of monocytic myeloid-derived suppressor cells through the nAChR/ERK pathway
Wanwei Zheng, Huan Song, Zhongguang Luo, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 11
Open Access | Times Cited: 61
Dysregulated Immunity and Immunotherapy after Sepsis
Dijoia B. Darden, Lauren S. Kelly, Brittany P. Fenner, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1742-1742
Open Access | Times Cited: 59
The emerging role of regulatory cell-based therapy in autoimmune disease
Farbod Ghobadinezhad, Nasim Ebrahimi, Fatemeh Mozaffari, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 58
Critical immunosuppressive effect of MDSC‑derived exosomes in the tumor microenvironment
Mohammad H. Rashid, Thaiz F. Borin, Roxan Ara, et al.
Oncology Reports (2021) Vol. 45, Iss. 3, pp. 1171-1181
Open Access | Times Cited: 57
How to improve photodynamic therapy-induced antitumor immunity for cancer treatment?
Min Zhang, Yifan Zhao, He Ma, et al.
Theranostics (2022) Vol. 12, Iss. 10, pp. 4629-4655
Open Access | Times Cited: 57
The role of CD71+ erythroid cells in the regulation of the immune response
Tomasz M. Grzywa, Dominika Nowis, Jakub Gołąb
Pharmacology & Therapeutics (2021) Vol. 228, pp. 107927-107927
Open Access | Times Cited: 56
Myeloid-Derived Suppressor Cells and Radiotherapy
Carlos Jiménez‐Cortegana, Claudia Galassi, Vanessa Klapp, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 5, pp. 545-557
Open Access | Times Cited: 56
Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment
Alain E. Andrea, Andrada Chiron, Sarah Mallah, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
A Metabolic Reprogramming Amino Acid Polymer as an Immunosurveillance Activator and Leukemia Targeting Drug Carrier for T‐Cell Acute Lymphoblastic Leukemia
Changzheng Li, Xinru You, Xi Xu, et al.
Advanced Science (2022) Vol. 9, Iss. 9
Open Access | Times Cited: 42
Reprogramming of sentinel lymph node microenvironment during tumor metastasis
Yen-Liang Li, Wen‐Chun Hung
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 38

Scroll to top